SCHEMBL6536574

SCHEMBL6536574

FCOc1[c]c(-c2ccccc2)ccc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6610213 0.81 ALDH1A1 (0.38)
SCHEMBL1888309 0.80
SCHEMBL336435 0.75 PDE4B (0.38)
SCHEMBL379055 0.72 ALDH1A1 (0.47)
SCHEMBL17714525 0.70 RXRA (0.35)
SCHEMBL8586499 0.67 MAOA (0.39)
SCHEMBL335715 0.67 ALDH1A1 (0.36)
SCHEMBL452876 0.66
SCHEMBL11345498 0.65 ALDH1A1 (0.38)
SCHEMBL8008263 0.64 CYP1A2 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1425015-A4 TETRAHYDROQUINOLINE DERIVATIVES AS ANTITHROMBOTIC AGENTS BRISTOL MYERS SQUIBB CO (US) 2004-12-15 EP disclosed
EP-1425015-A2 TETRAHYDROQUINOLINE DERIVATIVES AS ANTITHROMBOTIC AGENTS BRISTOL-MYERS SQUIBB COMPANY (US) 2004-06-09 EP disclosed
WO-2003015715-A2 TETRAHYDROQUINOLINE DERIVATIVES AS ANTITHROMBOTIC AGENTS BRISTOL-MYERS SQUIBB COMPANY (US) 2003-02-27 WO disclosed